Access Statistics for Toshiaki Iizuka

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems 0 0 0 55 4 6 21 69
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 0 17 4 6 18 64
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 0 10 6 7 17 60
Cognitive versus Physical Impairment and the Use and Cost of Long-Term Care in Japan 0 2 5 5 4 6 11 11
Drug Advertising and Health Habit 0 0 0 70 2 4 11 427
False Alarm? Estimating the Marginal Value of Health Signals 0 0 0 49 0 0 15 75
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 27 1 2 16 72
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 18 0 4 28 136
Is Zero a Special Price? Evidence from Child Healthcare 0 0 3 36 0 3 22 119
Long-term Care in Japan 0 0 4 24 3 8 46 80
Promoting Innovation in Small Markets: Evidence from the market for rare and intractable diseases 0 0 0 24 3 3 10 49
Robots and Labor in Nursing Homes 0 0 1 39 4 8 30 56
Robots and Labor in the Service Sector: Evidence from Nursing Homes 2 2 2 62 4 9 19 147
Total Working Papers 2 4 15 436 35 66 264 1,365


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Empirical Analysis of Planned Obsolescence 0 0 1 75 3 4 22 274
Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems 0 0 0 1 3 3 18 46
Asymmetric Demand Response When Prices Increase and Decrease: The Case of Child Health Care 0 0 2 8 1 3 20 115
Cartel sustainability in retail markets: Evidence from a health service sector 0 0 0 19 0 0 16 134
Comment on “How does the Price Regulation Policy Impact on Patient–Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?” 0 0 0 1 2 2 13 33
Comment on “Sustainable Health Financing for COVID‐19 Preparedness and Response in Asia and the Pacific” 0 0 0 5 2 3 8 17
DIRECT TO CONSUMER ADVERTISING AND PRESCRIPTION CHOICE 0 0 0 79 1 1 4 241
DURABLE GOODS PRICE CYCLES: THEORY AND EVIDENCE FROM THE TEXTBOOK MARKET 0 0 0 9 1 1 10 76
Does Higher Malpractice Pressure Deter Medical Errors? 0 0 0 36 5 5 12 153
Effect of age-based left-digit bias on stroke diagnosis: Regression discontinuity design 0 0 2 3 2 3 19 25
Experts' agency problems: evidence from the prescription drug market in Japan 0 0 0 34 1 2 19 151
False alarm? Estimating the marginal value of health signals 0 0 0 6 6 8 31 96
GENERIC ENTRY IN A REGULATED PHARMACEUTICAL MARKET* 0 0 0 34 4 5 10 130
Is Zero a Special Price? Evidence from Child Health Care 1 2 3 15 6 9 26 71
Patient cost sharing and medical expenditures for the Elderly 0 0 3 27 0 0 18 140
Physician Agency and Adoption of Generic Pharmaceuticals 0 0 5 67 3 4 19 302
Promoting innovation in small markets: Evidence from the market for rare and intractable diseases 0 0 0 3 1 1 10 41
Robots and labor in nursing homes 0 0 2 2 6 9 57 84
The Effect of Prescription Drug Advertising on Doctor Visits 0 0 2 83 3 3 21 344
The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program 0 0 0 12 1 1 22 61
The generic drug market in Japan: will it finally take off? 0 0 1 33 4 4 18 113
What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs? 0 0 0 119 2 4 14 444
Total Journal Articles 1 2 21 671 57 75 407 3,091


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Long-Term Care in Japan 0 0 0 0 2 3 5 5
Total Chapters 0 0 0 0 2 3 5 5


Statistics updated 2026-11-12